Cognitive impairment in patients with atrial fibrillation: What is the importance of anticoagulant therapy?

Submitted: April 24, 2018
Accepted: May 30, 2018
Published: June 7, 2018
Abstract Views: 2949
PDF: 533
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Atrial fibrillation represents one of the most significant aging markers and its prevalence increases with age, reaching 11.1% in men and 9.1% in women aged over 85 years. Fragility is nowadays defined according to two different phenotypes: the biologic-physiologic phenotype developed by L. Fried and Baltimora School and the clinic-multidimensional phenotype, proposed by Rockwood and Halifax School. If the clinical characteristics of elder patients hospitalized in acute geriatric unit care are considered, differences appear in the clinical features, in co-morbidity, in therapy and prognosis.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

How to Cite

Capobianco, Giovanni. 2018. “Cognitive Impairment in Patients With Atrial Fibrillation: What Is the Importance of Anticoagulant Therapy?”. Monaldi Archives for Chest Disease 88 (2). https://doi.org/10.4081/monaldi.2018.956.

Similar Articles

<< < 1 2 3 4 5 6 > >> 

You may also start an advanced similarity search for this article.